Blu Brain Medicine Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -9.24%
- Profit Growth -29.42%
- Ebitda 20.98%
- Net Worth 26.46%
- Total Assets -3.25%
About Blu Brain Medicine
Blu Brain Medicine Private Limited (BBMPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 11 May 2020 (Four years and eight months 29 days old ). Its registered office is in Warangal, Telangana, India.
The Company is engaged in the Education & Learing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sukumar Kandakatla and Manirathnam Kandakatla serve as directors at the Company.
Company Details
-
Location
Warangal, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U80903TG2020PTC140299
-
Company No.
140299
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 May 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Blu Brain Medicine?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sukumar Kandakatla
|
Director | 11-May-2020 | Current |
|
Manirathnam Kandakatla
|
Director | 11-May-2020 | Current |
Financial Performance of Blu Brain Medicine.
Blu Brain Medicine Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 9.24% decrease. The company also saw a substantial fall in profitability, with a 29.42% decrease in profit. The company's net worth Soared by an impressive increase of 26.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blu Brain Medicine?
Unlock access to Blu Brain Medicine's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Blu Brain Medicine?
Blu Brain Medicine has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blu Brain Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blu Brain Medicine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.